I agree that this site is using cookies. You can find further informations here.
X
Edan, Gilles
677  results:
Search for persons X
?
1

Long-term clinical outcomes in patients with CIS treated wi..:

Kappos, Ludwig ; Edan, Gilles ; Freedman, Mark S....
Journal of Neurology.  271 (2024)  7 - p. 4599-4609 , 2024
Link: https://doi.org/10.1007/..
 
?
2

L'expérience clinique de milliers de patients similaires à ..:

Demuth, Stanislas ; Paris, Julien ; Faddeenkov, Igor...
Revue Neurologique.  180 (2024)  - p. S149 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Scoping review of clinical decision support systems for mul..:

Demuth, Stanislas ; Ed‐Driouch, Chadia ; Dumas, Cédric...
European Journal of Neurology.  , 2024
Link: https://doi.org/10.1111/..
 
?
4

Serum metabolic profile in early multiple sclerosis as pred..:

Cortese, Marianna ; Peng, Xiaojing ; Bjornevik, Kjetil...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
5

Impact of automatic tools for detecting new lesions on ther..:

Merkler, Blandine ; Masson, Arthur ; Ferré, Jean Christophe...
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105064 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Long-term follow-up of patients with relapsing multiple scl..:

Giovannoni, Gavin ; Boyko, Alexey ; Correale, Jorge...
Multiple Sclerosis Journal.  29 (2023)  6 - p. 719-730 , 2023
Link: https://doi.org/10.1177/..
 
?
7

PRIMUS-Alpha : prototype de médecine de précision dans la s..:

Demuth, Stanislas ; Ed-Driouch, Chadia ; Rousseau, Olivia...
Revue Neurologique.  179 (2023)  - p. S152 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Escalation Versus Induction/High-Efficacy Treatment Strateg..:

Edan, Gilles ; Le Page, Emmanuelle
Drugs.  83 (2023)  15 - p. 1351-1363 , 2023
Link: https://doi.org/10.1007/..
 
?
9

A Plain Language Summary on Assessing the Long-Term Effecti..:

Giovannoni, Gavin ; Boyko, Alexey ; Correale, Jorge...
Neurodegenerative Disease Management.  13 (2023)  5 - p. 261-268 , 2023
Link: https://doi.org/10.2217/..
 
?
10

Switching from natalizumab administration at the day hospit..:

Lamy, Simon ; Veillard, David ; Doyen, Hélène...
Multiple Sclerosis and Related Disorders.  73 (2023)  - p. 104657 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Disease reactivation after fingolimod cessation in Multiple..:

Callens, Alix ; Leblanc, Soline ; Le Page, Emmanuelle...
Multiple Sclerosis and Related Disorders.  66 (2022)  - p. 104066 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Discontinuation of second- versus first-line disease-modify..:

Chappuis, Maëlle ; Rousseau, Chloé ; Bajeux, Emma...
Journal of Neurology.  270 (2022)  1 - p. 413-422 , 2022
Link: https://doi.org/10.1007/..
 
?
13

Severity of COVID19 infection among patients with multiple ..:

Simpson-Yap, Steve ; Pirmani, Ashkan ; De Brouwer, Edward...
Multiple Sclerosis and Related Disorders.  66 (2022)  - p. 104072 , 2022
Link: https://doi.org/10.1016/..
 
?
14

The agenda of the global patient reported outcomes for mult..:

Zaratin, Paola ; Vermersch, Patrick ; Amato, Maria Pia...
Multiple Sclerosis and Related Disorders.  61 (2022)  - p. 103757 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Comparative Effectiveness of Natalizumab Versus Anti-CD20 i..:

Rollot, Fabien ; Couturier, Justine ; Casey, Romain...
Neurotherapeutics.  19 (2022)  2 - p. 476-490 , 2022
Link: https://doi.org/10.1007/..
 
1-15